EFPIA - NEWSLETTER

EFPIA Newsletter 28 February 2019

Rare Disease Awareness Day: Show Your Rare, Show Your Care

EFPIA staff supports the Rare Disease Awareness Day

No one can win the fight against rare disease on their own. EFPIA reaffirms our industry’s commitment to working with all parts of the eco-system to tackle the burden of rare diseases.

More information about the Rare Disease Day is available here.

Blogs

28 February 2019 #WeWontRest until cancer patients and their families look to the future with hope rather than...

Developing innovative medicines making a meaningful difference to people living with cancer remains our number one job...

28 February 2019 Rare Disease Awareness Day: Tackling the burden of rare disease

No one can win the fight against rare disease on their own

28 February 2019 The need for incentives and concerted, collective, commitment to fight against AMR

EFPIA reaffirms its commitment to be a part of the fight against AMR

28 February 2019 Rare Disease Day: Spot on Sarcomas

A guest blog by Kathrin Schuster, SPAEN Communications

Videos

Children keep us up at night

And #WeWontRest until we’ve helped make the world a healthier place for every single one of them.

Stronger Together: Joining forces to fast-track results

Collaboration makes us stronger. Together we can transform the lives of patients - it is why #WeWontRest.
Read the full EFPIA Manifesto at: https://efpia.eu/manifesto/

Events

02 MAY 2019

ICHOM conference 2019 Rotterdam, The Netherlands

The world-leading event for providers, life sciences and industry on value-based healthcare

Learn more →

08 MAY 2019

2019 China/EU Pharmaceutical Industry Forum Hangzhou, China

The workshop covers 4 different themes: Pharmaceuticals in the Environment, Pricing & Reimbursement, Compliance (marketing...

Learn more →

What we are reading

Rare Disease Day: How the patient voice can tear down barriers 28 February 2019 (Pharmaphorum)

Auditors to probe EU efforts in tackling the worsening superbug problem 27 February 2019 (Science Business)

EU steps closer to generics and biosimilars manufacturing waiver 27 February 2019 (Pharmaphorum)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶